Loading chat...
HI HCR222
Concurrent Resolution
Status
3/8/2019
Primary Sponsor
Chris Lee
Click for details
AI Summary
-
Requests the FDA eliminate its one-year deferral policy for blood donations from men who have sex with men (MSM) implemented in December 2015.
-
Argues the one-year deferral does not align with FDA's blood testing windows and that other high-risk groups cited by the CDC lack similar restrictions.
-
Notes that 15 countries including Italy, Spain, and Mexico have eliminated or maintained no MSM blood donor bans or deferrals, with Italy's policy change showing no significant impact on HIV rates.
-
Cites a 2014 Williams Institute study finding that lifting MSM blood donor restrictions could increase annual U.S. blood supply by 2-4 percent, potentially saving more lives.
-
Requests FDA adopt individual risk assessment screening for all blood donors rather than lifestyle-based deferrals specific to MSM.
Legislative Description
Requesting The United States Food And Drug Administration To Eliminate Its Blood Donor Deferral Policy On The Collection Of Blood And Blood Components From Men Who Have Sex With Men.
Deferral
Last Action
Referred to HLT, FIN, referral sheet 33
3/14/2019